Related Experiment Video
Updated: Jul 16, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
Published on: June 4, 2012
[Infective endocarditis in an internal medicine ward]
Alvaro Hermida Ameijeiras1, Raimundo López Rodríguez, Montserrat Rodríguez Framil
1Servicio de Medicina Interna, Hospital Clínico, Santiago de Compostela (A Coruña), España. alvarohermida@tiscali.es
Insights
Infective endocarditis (IE) affects diverse patient groups, with intravenous drug users and the elderly facing higher risks. Tailored approaches are crucial for managing this prevalent condition.
Area of Science:
- Cardiology
- Infectious Diseases
- Internal Medicine
Context:
- Infective endocarditis (IE) remains a significant health concern with high mortality rates.
- Increasing prevalence in intravenous drug users, immunocompromised individuals, and those with prosthetic valves.
Purpose:
- To review all diagnosed cases of infective endocarditis (IE) within an Internal Medicine Service.
- Analyze patient demographics, risk factors, causative agents, and outcomes.
Summary:
- Retrospective review of 87 definite IE cases (1989-2003) identified Staphylococcus aureus as a common cause in intravenous drug users, associated with embolism risk.
- Older patients (>70 years) and those with prosthetic valves faced increased mortality and complications like abscesses.
- Hospital-acquired IE was linked to advanced age and IV catheters; prosthetic valve endocarditis showed higher mortality.
Impact:
- Highlights the need for individualized patient assessment considering age, drug use, and prosthetic valve status.
- Informs clinical practice for better diagnosis and management of infective endocarditis.
- Emphasizes the importance of risk stratification for improved patient outcomes in IE.
Background:
Due to the increasing number of intravenous drug users, subjects with immune deficiencies or with prosthetic valves, infective endocarditis (IE) continues to be prevalent and to have a high mortality.
Aim:
To review all cases of infective endocarditis diagnosed in an Internal Medicine Service.
Material And Methods:
Retrospective review of medical records of all patients with infective endocarditis, hospitalized in an Internal Medicine ward, between 1989 and 2003. Dukes criteria were used to define definitive, possible and less probable cases of IE.
Results:
Eighty seven patients with definite IE were identified (66 males, age range 19-84 years), with a mean incidence of 5.3 per 1000 hospitalizations. IE in intravenous drugs users was usually caused by Staphylococcus aureus and presented high risk of embolism (RR: 3,21). Subjects aged over 70 years had a relative risk of mortality of 5.5. Hospital acquired IE was associated with advanced age and IV catheters appeared as the only predisposing factor. Patients with prosthetic valves were also older, their main complication was abscess formation and their mortality was higher.
Conclusions:
A closer approach to differential conditions of patients, according to age, intravenous drug use or the presence of prosthetic valves, is necessary.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis IV: Nursing Management
Endocarditis III: Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis
Myocarditis III: Medical Management
Myocarditis I: Introduction
